PubRank

W F Crowley

Author PubWeight™ 144.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004 4.24
2 The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med 1994 2.06
3 Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev 1998 2.05
4 Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest 1996 1.97
5 Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991 1.94
6 Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med 1982 1.89
7 Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 2000 1.84
8 The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 1985 1.71
9 Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med 1992 1.69
10 Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility. N Engl J Med 1997 1.66
11 Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2001 1.65
12 Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994 1.61
13 Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr Rev 1986 1.56
14 The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 2001 1.56
15 CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome. Clin Genet 2008 1.56
16 Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med 1977 1.55
17 Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod 1999 1.45
18 Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 2006 1.41
19 Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 2006 1.38
20 The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 1996 1.33
21 The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab 2001 1.26
22 Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986 1.24
23 Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987 1.23
24 Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). J Clin Endocrinol Metab 1980 1.22
25 A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 1983 1.19
26 Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989 1.18
27 X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 1999 1.17
28 Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981 1.17
29 Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med 1981 1.16
30 Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol 1988 1.15
31 Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J Clin Endocrinol Metab 2000 1.14
32 A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J Clin Endocrinol Metab 1997 1.14
33 Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988 1.14
34 Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Endocr Rev 1986 1.13
35 Translational careers. Science 2009 1.13
36 Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 2001 1.12
37 Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 1984 1.12
38 Kisspeptin and GPR54: discovery of a novel pathway in reproduction. J Neuroendocrinol 2008 1.12
39 Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. N Engl J Med 1983 1.10
40 Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumors. J Clin Endocrinol Metab 1994 1.08
41 Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 1997 1.02
42 Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab 1991 0.99
43 Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab 1991 0.99
44 The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987 0.98
45 Spatial ability in androgen-deficient men. N Engl J Med 1982 0.98
46 The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 2001 0.97
47 A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation. J Clin Endocrinol Metab 1994 0.96
48 Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 1999 0.95
49 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 1994 0.95
50 Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome. J Endocrinol Invest 1998 0.95
51 Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men. J Clin Endocrinol Metab 1987 0.94
52 Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women. J Clin Endocrinol Metab 1995 0.93
53 Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women. Proc Natl Acad Sci U S A 1994 0.93
54 Heterogeneous expression of the potassium-chloride cotransporter KCC2 in gonadotropin-releasing hormone neurons of the adult mouse. Endocrinology 2003 0.93
55 The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab 1994 0.92
56 Perspective: the importance of genetic defects in humans in elucidating the complexities of the hypothalamic-pituitary-gonadal axis. Endocrinology 2001 0.92
57 Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab 1997 0.92
58 Myocardial function in hypothyroidism. Relation to disease severity and response to treatment. Arch Intern Med 1978 0.92
59 Gonadotropin pulsations across development. Horm Res 1998 0.91
60 Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men. J Clin Endocrinol Metab 1986 0.91
61 Importance of inhibin B in the regulation of FSH secretion in the human male. J Clin Endocrinol Metab 2001 0.91
62 Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology 1996 0.90
63 Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab 1992 0.90
64 Progesterone antagonism: science and society. N Engl J Med 1986 0.90
65 Clinical review 4: Diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J Clin Endocrinol Metab 1990 0.89
66 Divergent responses of gonadotropin subunit messenger RNAs to continuous versus pulsatile gonadotropin-releasing hormone in vitro. Mol Endocrinol 1990 0.89
67 Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 1992 0.88
68 Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. J Clin Endocrinol Metab 1990 0.88
69 Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically. Endocrinology 1996 0.87
70 Clinical review 96: Differential control of gonadotropin secretion in the human: endocrine role of inhibin. J Clin Endocrinol Metab 1998 0.87
71 Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology 1993 0.86
72 Dynamic regulation of follicle-stimulating hormone-beta messenger ribonucleic acid levels by activin and gonadotropin-releasing hormone in perifused rat pituitary cells. Endocrinology 1992 0.86
73 Hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am 1998 0.86
74 The effects of continuous androgen secretion on the hypothalamic-pituitary axis in woman: evidence from a luteinized thecoma of the ovary. J Clin Endocrinol Metab 1984 0.86
75 Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 1996 0.85
76 Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty. J Clin Endocrinol Metab 1988 0.85
77 Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 1994 0.85
78 How do academic health centers value and encourage clinical research? Acad Med 2001 0.85
79 Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. J Clin Endocrinol Metab 1999 0.85
80 Utility of free alpha-subunit as an alternative neuroendocrine marker of gonadotropin-releasing hormone (GnRH) stimulation of the gonadotroph in the human: evidence from normal and GnRH-deficient men. J Clin Endocrinol Metab 1990 0.85
81 Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1993 0.85
82 The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. N Engl J Med 1980 0.84
83 A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 1996 0.84
84 A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab 1998 0.83
85 Interpulse interval of GnRH stimulation independently modulates LH secretion. Am J Physiol 1989 0.83
86 Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. J Clin Endocrinol Metab 1988 0.83
87 Genetics of hypogonadotropic hypogonadism. J Endocrinol Invest 2000 0.83
88 Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization. Obstet Gynecol 1985 0.83
89 Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after shortterm physiologic GnRH replacement--a clinical research center study. J Clin Endocrinol Metab 1996 0.82
90 Improved measurement of free alpha subunit of glycoprotein hormones by assay with use of a monoclonal antibody. Clin Chem 1988 0.82
91 Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men. J Clin Endocrinol Metab 1989 0.82
92 The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease. J Clin Endocrinol Metab 1985 0.82
93 Immunoreactive inhibin alpha-subunit in human serum: implications for radioimmunoassay. J Clin Endocrinol Metab 1990 0.82
94 Contour of the GnRH pulse independently modulates gonadotropin secretion in the human male. Neuroendocrinology 1996 0.81
95 Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children. J Clin Endocrinol Metab 1991 0.81
96 Gonadotropin-releasing hormone-induced stimulation and desensitization of free alpha-subunit secretion mirrors luteinizing hormone and follicle-stimulating hormone in perifused rat pituitary cells. Endocrinology 1990 0.81
97 Pituitary and gonadal responsiveness is enhanced during GnRH-induced puberty. Am J Physiol 1988 0.81
98 Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche. J Clin Invest 1986 0.81
99 Impact of sex steroids and their suppression on skeletal growth and maturation. Am J Physiol 1988 0.80
100 Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. J Clin Invest 1988 0.80
101 The mortician's mystery. Gynecomastia and reversible hypogonadotropic hypogonadism in an embalmer. N Engl J Med 1988 0.80
102 Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage. J Clin Endocrinol Metab 1986 0.80
103 Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects. Ann Intern Med 1986 0.80
104 Normal structure of the gonadotropin-releasing hormone (GnRH) gene in patients with GnRH deficiency and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989 0.79
105 Endocrine impact of pure estradiol replacement in postmenopausal women: alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations. Am J Obstet Gynecol 1986 0.79
106 Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J Clin Endocrinol Metab 1997 0.79
107 Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies. J Clin Endocrinol Metab 1987 0.79
108 Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment--a clinical research center study. J Clin Endocrinol Metab 1996 0.79
109 Alterations of the hypothalamic GnRH interpulse interval sequence over the normal menstrual cycle. Am J Physiol 1988 0.79
110 Epitope mapping of human luteinizing hormone using monoclonal antibodies. Endocrinology 1988 0.79
111 Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human. J Clin Endocrinol Metab 1991 0.79
112 Absence of mutations in the FSH receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metab 1998 0.79
113 Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. J Clin Endocrinol Metab 1990 0.79
114 Gonadotropin-releasing hormone: molecular and cell biology, physiology, and clinical applications. Fed Proc 1984 0.78
115 Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1998 0.78
116 Gonadotrophin-releasing hormone agonist treatment of central precocious puberty: an analysis of growth data in a developmental context. Acta Paediatr Scand Suppl 1990 0.78
117 Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle. J Clin Endocrinol Metab 1996 0.78
118 Validation of highly specific and sensitive radioimmunoassays for lutropin, follitropin, and free alpha subunit in unextracted urine. Clin Chem 1990 0.78
119 Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model. Neuroendocrinology 1998 0.78
120 Interpulse interval sequence of LH in normal men essentially constitutes a renewal process. Am J Physiol 1986 0.78
121 The gonadotropin genes: evolution of distinct mechanisms for hormonal control. Recent Prog Horm Res 1996 0.78
122 Homologous desensitization of gonadotropin-releasing hormone (GnRH)-stimulated luteinizing hormone secretion in vitro occurs within the duration of an endogenous GnRH pulse. Endocrinology 1995 0.77
123 Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology 1991 0.77
124 Altered patterns of pituitary secretion and renal excretion of free alpha-subunit during gonadotropin-releasing hormone agonist-induced pituitary desensitization. J Clin Endocrinol Metab 1991 0.77
125 Pituitary luteinizing hormone responses to intravenous and subcutaneous administration of gonadotropin-releasing hormone in men. J Clin Endocrinol Metab 1985 0.77
126 Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2014 0.77
127 Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab 1995 0.77
128 Development of a bioassay for FSH using a recombinant human FSH receptor and a cAMP responsive luciferase reporter gene. Mol Cell Endocrinol 1994 0.77
129 Pulsatile gonadotropin-releasing hormone modifies polyadenylation of gonadotropin subunit messenger ribonucleic acids. Endocrinology 1992 0.77
130 Normal sequence of the gonadotropin-releasing hormone gene in patients with idiopathic hypogonadotropic hypogonadism. Biol Reprod 1991 0.77
131 An improved method of purifying inhibin radioligand for radioimmunoassay. Biol Reprod 1990 0.77
132 Human follicular fluid contains pro- and C-terminal immunoreactive alpha-inhibin precursor proteins. J Clin Endocrinol Metab 1994 0.76
133 Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. J Clin Endocrinol Metab 1989 0.76
134 Hypothalamic control of gonadotropin secretion in the human menstrual cycle. Prog Clin Biol Res 1986 0.76
135 Male hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am 1993 0.76
136 Perifused pituitary cultures: a model for LHRH regulation of LH secretion. Am J Physiol 1981 0.76
137 An overview of LHRH and its analogues: clinical uses. Ups J Med Sci 1984 0.76
138 Activin: an endocrine or paracrine agent? Eur J Endocrinol 1998 0.76
139 The genetics of IHH--a paradox. Clin Endocrinol (Oxf) 2001 0.75
140 Neuroendocrine control of reproduction and its therapeutic manipulation with GnRH and its analogs. Int J Fertil 1985 0.75
141 Gonadotropin-releasing hormone (GnRH) physiology in men and women. Acta Med Hung 1986 0.75
142 New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome. Ann N Y Acad Sci 1993 0.75
143 Activin-binding proteins in human serum and follicular fluid. J Clin Endocrinol Metab 1992 0.75
144 Gonadotrophin-releasing hormone analogues as therapeutic probes in human growth and development: evidence from children with central precocious puberty. Acta Paediatr Scand Suppl 1991 0.75
145 Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls. J Clin Ultrasound 1986 0.75
146 Effects of chronic GnRH analogue administration on gonadotrophin and alpha-subunit secretion in post-menopausal women. Clin Endocrinol (Oxf) 1992 0.75
147 Hypogonadotropic hypogonadism: gonadotropin-releasing hormone therapy. Curr Ther Endocrinol Metab 1994 0.75
148 The natural history of autonomous gonadal function, adrenarche, and central puberty in gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1992 0.75
149 Development of a radioligand receptor assay for measuring follitropin in serum: application to premature ovarian failure. Clin Chem 1991 0.75
150 Development of a male contraceptive--a beginning. N Engl J Med 1981 0.75
151 A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab 1996 0.75
152 Hypogonadotrophic hypogonadism: a unique biological opportunity. Clin Endocrinol (Oxf) 1999 0.75
153 Defective regulation of glycoprotein free alpha-subunit in males with isolated gonadotropin-releasing hormone deficiency--a clinical research center study. J Clin Endocrinol Metab 1995 0.75
154 Extragonadal alpha-inhibin precursor proteins circulate in human male serum. J Clin Endocrinol Metab 1995 0.75
155 Sensitivity differences in reproductive/endocrine organs to chronically administered LHRH agonists in female rats. Life Sci 1987 0.75
156 The study of GnRH control of reproductive function. Ups J Med Sci 1984 0.75
157 Citation for the 1997 Fred Conrad Koch Award of The Endocrine Society to Wylie Vale. Endocr Rev 1997 0.75
158 Closed intravenous administration of gonadotropin-releasing hormone: safety of extended peripheral intravenous catheterization. Obstet Gynecol 1989 0.75
159 Administration of low dose pulsatile gonadotropin-releasing hormone (GnRH) to GnRH-deficient men regulates free alpha-subunit secretion. J Clin Endocrinol Metab 1986 0.75
160 The Reproductive Endocrine Associates of the Massachusetts General Hospital: fifteen years of integrated clinical practice and investigation. J Clin Endocrinol Metab 1999 0.75
161 Citation for the 1996 Rhône-Poulenc Rorer Clinical Investigator Award of The Endocrine Society to Andrea Dunaif. Endocr Rev 1996 0.75
162 Priapism in hypogonadal men receiving gonadotropin releasing hormone. J Urol 1991 0.75
163 Sonographic morphology of the normal menstrual cycle. Radiology 1979 0.75
164 Hypogonadotropic hypogonadism: gonadotropin-releasing hormone therapy. Curr Ther Endocrinol Metab 1997 0.75